Management tracks: Chugai, bioMérieux

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said President and COO Tatsuro Kosaka will become president and CEO. He succeeds CEO Osamu Nagayama, who will remain chairman.

Diagnostics company bioMérieux S.A. (Euronext:BIM) said Deputy CEO Alexandre Mérieux will become to chairman

Read the full 383 word article

How to gain access

Continue reading with a
two-week free trial.